Patents by Inventor Chuen Chan

Chuen Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolidine derivatives as factor Xa inhibitors
    Patent number: 7517879
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: April 14, 2009
    Assignee: Glaxo Group Limited
    Inventors: Chuen Chan, Julie Nicole Hamblin, Henry Anderson Kelly, Nigel Paul King, Andrew McMurtrie Mason, Vipulkumar Kantibhai Patel, Stefan Senger, Gita Punjabhai Shah, Nigel Stephen Watson, Helen Elisabeth Weston, Caroline Whitworth, Robert John Young
  • Pyrrolidine derivatives as factor Xa inhibitors
    Patent number: 7429587
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: September 30, 2008
    Assignee: Glaxo Group Limited
    Inventors: Chuen Chan, Julie Nicole Hamblin, Henry Anderson Kelly, Nigel Paul King, Andrew McMurtrie Mason, Vipulkumar Kantibhai Patel, Stefan Senger, Gita Punjabhai Shah, Nigel Stephen Watson, Helen Elisabeth Weston, Caroline Whitworth, Robert John Young
  • 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases
    Patent number: 7329685
    Abstract: The invention relates to compounds of formula (I): wherein substituents are as defined.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: February 12, 2008
    Assignee: Glaxo Group Limited
    Inventors: Alan David Borthwick, Chuen Chan, Henry Anderson Kelly, Savvas Kleanthous, Andrew McMurtrie Mason, Nigel Stephen Watson
  • Pyrrolidine derivatives as factor XA inhibitors
    Patent number: 7326785
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: February 5, 2008
    Assignee: Glaxo Group Limited
    Inventors: Chuen Chan, Julie Nicole Hamblin, Henry Anderson Kelly, Nigel Paul King, Andrew McMurtrie Mason, Vipulkumar Kantibhai Patel, Stefan Senger, Gita Punjabhai Shah, Nigel Stephen Watson, Helen Elisabeth Weston, Caroline Whitworth, Robert John Young
  • Pyrrolidin-2-one derivatives as inhibitors of factor xa
    Patent number: 7282497
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: October 16, 2007
    Assignee: Glaxo Group Limited
    Inventors: Chuen Chan, Julie Nicole Hamblin, Henry Anderson Kelly, Nigel Paul King, Andrew McMurtrie Mason, Vipulkumar Kantibhai Patel, Stefan Senger, Gita Punjabhai Shah, Nigel Stephen Watson, Helen Elisabeth Weston, Caroline Whitworth, Robert John Young
  • PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORS
    Publication number: 20070155745
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: October 11, 2006
    Publication date: July 5, 2007
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORS
    Publication number: 20070142375
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: October 11, 2006
    Publication date: June 21, 2007
    Inventors: Chuen CHAN, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORS
    Publication number: 20070142374
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: October 11, 2006
    Publication date: June 21, 2007
    Inventors: Chuen CHAN, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Carolin Whitworth, Robert Young
  • Pyrrolidin-2-one derivatives as inhibitors of factor xa
    Patent number: 7226929
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: June 5, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Chuen Chan, Julie Nicole Hamblin, Henry Anderson Kelly, Nigel Paul King, Andrew McMurtrie Mason, Vipulkumar Kantibhai Patel, Stefan Senger, Gita Punjabhai Shah, Nigel Stephen Watson, Helen Elisabeth Weston, Caroline Whitworth, Robert John Young
  • Pyrrolidine derivatives as Factor Xa inhibitors
    Patent number: 7186717
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: March 6, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Chuen Chan, Julie Nicole Hamblin, Henry Anderson Kelly, Nigel Paul King, Andrew McMurtrie Mason, Vipulkumar Kantibhai Patel, Stefan Senger, Gita Punjabhai Shah, Nigel Stephen Watson, Helen Elisabeth Weston, Caroline Whitworth, Robert John Young
  • 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
    Patent number: 7179835
    Abstract: The invention relates to compounds of formula (I) pharmaceutical compositions containing the same as well as methods of treating patients suffering from a condition susceptible to amelioration by a Factor Xa inhibitor using the same.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: February 20, 2007
    Assignee: Glaxo Group Limited
    Inventors: Alan David Borthwick, Matthew Campbell, Chuen Chan, Henry Anderson Kelly, Nigel Paul King, Savvas Kleanthous, Andrew McMurtrie Mason, Stefan Senger, Paul William Smith, Nigel Stephen Watson, Robert John Young
  • Pyrrolidin-2-one derivatives as inhibitors of factor Xa
    Patent number: 7084139
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: August 1, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Chuen Chan, Julie Nicole Hamblin, Henry Anderson Kelly, Nigel Paul King, Andrew McMurtrie Mason, Vipulkumar Kantibhai Patel, Stefan Senger, Gita Punjabhai Shah, Nigel Stephen Watson, Helen Elisabeth Weston, Caroline Whitworth, Robert John Young
  • Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa
    Publication number: 20060166985
    Abstract: The invention relates to novel chemical compounds, pharmaceutically acceptable derivatives thereof, processes for their preparation, pharmaceutical compositions containing them, and to their use in medicine, particularly use in the amelioration of a clinical condition for which a thrombin inhibitor is indicated.
    Type: Application
    Filed: December 4, 2003
    Publication date: July 27, 2006
    Inventors: Alan Borthwick, Chuen Chan, Henry Kelly, Simon Peace, Stefan Senger, Gita Shah, Stefan Smith, Steven Smith, Nigel Watson, Robert West, Robert Young
  • Chemical compounds
    Publication number: 20060160886
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 20, 2006
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • Chemical compounds
    Publication number: 20060160885
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 20, 2006
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
    Publication number: 20060148879
    Abstract: The invention relates to compounds of formula (I): wherein substituents are as defined.
    Type: Application
    Filed: June 17, 2004
    Publication date: July 6, 2006
    Inventors: Alan Borthwick, Chuen Chan, Henry Kelly, Savvas Kleanthous, Andrew Mason, Nigel Watson
  • Pyrrolidine derivatives as factor xa inhibitors
    Publication number: 20050107379
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: June 6, 2002
    Publication date: May 19, 2005
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • Pyrrolidine-2-ones as factor xa inhibitors
    Publication number: 20050059726
    Abstract: The present invention relates to novel compounds and pharmaceutically acceptable derivatives thereof. The invention also relates to processes for the preparation of the compounds, pharmaceutical compositions containing the compounds, and to the use of compounds in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: December 20, 2002
    Publication date: March 17, 2005
    Inventors: Alan Borthwick, Chuen Chan, Henry Kelly, Nigel King, Savvas Kleanthous, Andrew Mason, Ivan Pinto, Derek Pollard, Stefan Senger, Gita Shah, Nigel Watson, Robert Young
  • 2-(3-Sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
    Publication number: 20050004119
    Abstract: The invention relates to compounds of formula (I) pharmaceutical compositions containing the same as well as methods of treating patients suffering from a condition susceptible to amelioration by a Factor Xa inhibitor using the same.
    Type: Application
    Filed: November 13, 2002
    Publication date: January 6, 2005
    Inventors: Alan Borthwick, Matthew Campbell, Chuen Chan, Henry Kelly, Nigel King, Savvas Kleanthous, Andrew Mason, Stefan Senger, Paul Smith, Nigel Watson, Robert Young
  • Pyrrolidin-2-one derivatives as inhibitors of factor xa
    Publication number: 20040152697
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: December 3, 2003
    Publication date: August 5, 2004
    Inventors: Chuen Chan, Julie Nicole Hamblin, Henry Anderson Kelly, Nigel Paul King, Andrew McMurtrie Mason, Vipulkumar Kantibhai Patel, Stefan Senger, Gita Punjabhai Shah, Nigel Stephen Watson, Helen Elisabeth Weston, Caroline Whitworth, Robert John Young